Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Guddo

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Pathology|February 4, 1999
MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patientsF Guddo, A Giatromanolaki, M I Koukourakis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancerM I Koukourakis, A Giatromanolaki, F Guddo, et al.
Anticancer Research|July 25, 1998
Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progressionF Guddo, A Giatromanolaki, C Patriarca, et al.
Pathologica|September 28, 2018
The 2015 World Health Organization Classification of lung tumors: new entities since the 2004 ClassificationM C Mengoli, F R Longo, F Fraggetta, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Pathology|February 4, 1999
MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patientsF Guddo, A Giatromanolaki, M I Koukourakis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancerM I Koukourakis, A Giatromanolaki, F Guddo, et al.
Anticancer Research|July 25, 1998
Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progressionF Guddo, A Giatromanolaki, C Patriarca, et al.
Pathologica|September 28, 2018
The 2015 World Health Organization Classification of lung tumors: new entities since the 2004 ClassificationM C Mengoli, F R Longo, F Fraggetta, et al.
Pageof 2